High incidence of de novo diabetes mellitus type 1 during or after treatment with pegylated interferon in patients with chronic hepatitis C virus infection

被引：0
|
作者：
Schreuder, T. C. M. A.
Gelderblom, H. G.
Weegink, C. J.
Reesink, H. W.
Hoekstra, J. B. L.
Jansen, P. L. M.
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80607-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
607
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [1] High incidence of de novo diabetes mellitus type 1 during or after treatment with pegylated interferon in patients with chronic hepatitis C virus infection
    Hoekstra, J.
    Schreuder, T.
    Gelderblom, H.
    Weegink, C.
    Reesink, H.
    DeVries, J.
    Jansen, P.
    [J]. DIABETOLOGIA, 2006, 49 : 501 - 502
  • [2] High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection
    Schreuder, Tim C. M. A.
    Gelderblom, Huub C.
    Weegink, Christine J.
    Hamann, Dorte
    Reesink, Henk W.
    DeVries, J. Hans
    Hoekstra, Joost B. L.
    Jansen, Peter L. M.
    [J]. LIVER INTERNATIONAL, 2008, 28 (01) : 39 - 46
  • [3] Onset of Type 1 Diabetes Mellitus During Pegylated-interferon Alfa and Ribavirin Therapy for Chronic Hepatitis C Virus Infection
    Ranganathan, Raghini
    Janarthanan, Krishnaveni
    Rajasekaran, Senthilkumar
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (01) : 86 - 87
  • [4] Lipoatrophy After Pegylated Interferon Treatment for Chronic Hepatitis C Virus Infection
    Konstantakis, Christos
    Karamesini, Maria
    Triantos, Christos
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (09) : E139 - E140
  • [5] Chronic hepatitis C virus infection in dialysis patients and treatment with pegylated interferon
    Sikole, A
    Dzekova, P
    Asani, A
    Selim, GJ
    Amitov, V
    Gelev, S
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2006, 29 (05): : 502 - 502
  • [6] Is the type of pegylated interferon important for response to treatment in patients with chronic hepatitis C infection?
    Buti, Maria
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (03): : 125 - 126
  • [7] First expiriences of treatment of dialysis patients with chronic hepatitis C virus infection with pegylated interferon
    Dzekova, Pavlina
    Asani, Arben
    Selim, Gulsen
    Gelev, Saso
    Amitov, Vili
    Zafirovska, K.
    Sikole, Aleksandar
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 99 - 99
  • [8] The high prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection
    Igea, FJG
    Serrano, AG
    Jiménez, JAL
    Gil, SP
    [J]. MEDICINA CLINICA, 1998, 111 (17): : 676 - 677
  • [9] Frequency of Type 2 Diabetes Mellitus in Patients with Chronic Hepatitis C Virus Infection
    Ghouri, Aslam
    Kumar, Santosh
    Khan, Sajjad Ahmed
    Ghani, Mohammad Hanif
    Aslam, Soniha
    Asadullah
    [J]. JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2014, 13 (02): : 51 - 56
  • [10] PREVALENCE OF DIABETES MELLITUS TYPE 2 IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
    Kaur, Ranjeet
    Mohan, Gurinder
    Bhalla, Narotam
    Kaur, Baldeep
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (07): : 1184 - 1196
12345